
Scenic Biotech BV announces $31m financing
The round was co-led by seasoned European investors, Eir Ventures, a Nordic Life Science venture fund, Switzerland-based BioMedPartners and...

Four new autoantigens trigger multiple sclerosis
Despite considerable progress in the treatment of multiplesclerosis (MS), the disease still often leads to permanent neurological disability....

Avantium gets EU grant
Avantium said it will use the EU grant from the Horizon Europe programme for its participation in the 4-year research and development programme...

GSK acquires Sierra Oncology for 1.9bn
GSK is paying $1.9 bn in cash ($55 per share) for the deal. This is a 39 per cent premium to the Sierra share price on 12 April and a 63 per cent...

AXA launches €440 m private equity healthcare strategy
The Strategy focuses specifically on companies in four core areas: medical devices, biopharmaceuticals, vaccines, and diagnostics. The...

Hot of the press: BIOTECH Insight Newsletter
According to the results of the Biotechnology Company Survey 2022 conducted by BIOCOM AG (Berlin), the turnover of the German biotech sector grew...

ECBF oversubscribed closing at €300m
According to the industry experts, the biologisation of industrial production by means of sustainable bacterial-enzymatic or cell-culture-based...